Trial Details
COMPLETEDBasic Information
| Clinical ID | c3372 |
|---|---|
| Identifier | NCT02154425 |
| Trial Title | A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Axial Spondyloarthritis (AxSpA)|Non-radiographic Evidence-AxSpA|Ankylosing Spondylitis|Crohn's Disease|Psoriatic Arthritis|Rheumatoid Arthritis |
| Interventions | PROCEDURE: Breast milk sampling|BIOLOGICAL: Certolizumab Pegol |
Participant Information
| Sponsor | UCB BIOSCIENCES, Inc. |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2014-09 |
|---|---|
| Primary Completion Date | 2015-12 |
| Completion Date | 2016-01 |